Clinical Trial Update: Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab in combination with mycophenolate mofetil for highly sensitized patients awaiting kidney transplantation; the study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy
• Hypertensive Nephropathy
• Iga Nephropathy

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Rituxan (rituximab)

Snippet

Sponsor: University of Washington | Conditions: Kidney Failure, Chronic, Diabetic Nephropathies | Phase 2 | Status: COMPLETED | Results posted: 2010-03-29